Stocks Screeners Features Pricing
Sign In Get Started

Kenvue Stock Analysis

NYSE: KVUE | Consumer Staples | Personal Care Products
Price $19.01 $0.23 (-1.20%)
P/E Ratio 22.4 TTM
52-Week Range
Low $14 High $22
Market Cap $36.58B USD
ROE 13.7% Annual

Market data as of Aug 3, 2026 · Financials as of Dec 2025

Published Jun 21, 2026

Kenvue (KVUE) gets examined here through its financial statements, valuation metrics, and capital allocation track record.

Revenue Trend

On the revenue front, the picture isn't encouraging: Kenvue posted $15.12B in FY2025, a 2.1% decline from FY2024 levels.

Over the past 5 years, revenue has compounded at just 0.9% annually, moving from $14.47B to $15.12B. That pace barely clears inflation.

With $15.12B in annual revenue, Kenvue sits in mid-cap territory within the consumer staples space.

Revenue Trend
Year Revenue YoY %
FY2025 $15.12B -2.1%
FY2024 $15.46B +0.1%
FY2023 $15.44B +3.3%
FY2022 $14.95B -0.7%
FY2021 $15.05B +4.1%

View the detailed revenue trend and growth analysis

Revenue by Segment

Kenvue breaks its revenue across 3 product segments. The FY2025 split is shown below.

Revenue by Product Segment (FY2025)

Self Care42.2% · $6.38B
Essential Health30.6% · $4.63B
Skin Health and Beauty27.2% · $4.11B
SegmentRevenue% of Total
Self Care$6.38B42.2%
Essential Health$4.63B30.6%
Skin Health and Beauty$4.11B27.2%

Self Care is Kenvue's clear revenue leader, accounting for 42.2% of total sales.

Geographically, revenue is spread across North America (48%), EMEA (25%), Asia Pacific (18%), and Latin America (9%).

Kenvue Earnings & Margins

Net income jumped 42.7% year-over-year in FY2025, climbing from $1.03B to $1.47B.

The net profit margin widened to 9.7% in FY2025 from 6.7% in FY2024, reflecting improved cost discipline.

Diluted EPS came in at $0.76 for FY2025, up from $0.54 in the prior year.

Explore the profitability trend in detail below

Dividends & Shareholder Returns

Kenvue paid out $0.82 per share in dividends in FY2025, translating to a yield of roughly 4.53%.

A payout ratio of 108.1% leaves little cushion at Kenvue. Any softness in earnings could put the dividend under pressure.

Dividend History
Year DPS Payout Ratio
FY2025 $0.82 108.1%
FY2024 $0.81 149.5%
FY2023 $7.60 873.5%

Over the past 2 years, Kenvue has put $432.0M to work buying back its own shares.

View the full share repurchase and dilution trend

Kenvue's Balance Sheet Health

Balance Sheet Snapshot (FY2025)
Metric Value
Cash & Short-term Investments $1.06B
Total Debt $8.52B
Shareholders' Equity $10.77B
Total Assets $27.08B
Debt-to-Equity Ratio 0.79x
Current Ratio 0.96x
Interest Coverage 7.1x
Free Cash Flow (TTM) $1.72B

A debt-to-equity ratio of 0.79, a current ratio of 0.96, and interest coverage of 7.1x in FY2025 together point to a well-capitalized balance sheet carrying manageable debt.

Kenvue carries $8.52B in debt against $1.06B in cash, and its 0.79x D/E ratio confirms the balance sheet remains adequately capitalized.

Interest coverage sits at 7.1x, meaning Kenvue's operating income covers its interest obligations with room to spare.

Free cash flow of $1.72B gives Kenvue solid capacity to fund dividends, buybacks, and debt reduction simultaneously.

See the detailed financial health breakdown in the charts

Kenvue's FY2025 headcount stood at 22,000, putting revenue per employee at roughly $687.5K.

See Kenvue's full employee count history and revenue per employee

Valuation Check: Is Kenvue Overpriced?

So is Kenvue stock overvalued or undervalued? The valuation models below offer some perspective.

Kenvue shares are currently trading at $19.01.

Applying the P/E Ratio model produces a fair value of $18 for Kenvue.

Intrinsic value is also estimated using the DCF and EPS Growth models. Sign up to see the full breakdown with fair value estimates.

Valuation Models
Model Est. Fair Value vs. Current Price
P/E Ratio $18 8.1% downside to fair value
DCF Upgrade Upgrade
EPS Growth Upgrade Upgrade

Key Highlights

Pulling back to survey Kenvue's overall financial position: the data offers a fairly clear picture for anyone evaluating this consumer staples stock.

FY2025 revenue of $15.12B, down 2.1% from the prior year.

Over a 5-year horizon, revenue has compounded at 0.9% per year.

Profitability is solid, with a net margin of 9.7% and net income of $1.47B.

Capital returned to shareholders totaled $1.78B in FY2025 via dividends and/or buybacks.

The balance sheet is conservative, carrying a D/E ratio of 0.79x.

The P/E Ratio model implies 8.1% downside to fair value. The remaining 2 models are worth cross-checking before drawing a conclusion. Sign up to see the full analysis.

The charts below contain Kenvue's complete financial data, including valuation models and historical trends.

Frequently Asked Questions

Is Kenvue's revenue growing?
Kenvue's revenue was $15.12B in FY2025, down 2.1% from the prior year.
What are Kenvue's profit margins?
Kenvue's net profit margin was 9.7% in FY2025.
Does Kenvue pay a dividend?
Yes, Kenvue pays a regular dividend to shareholders.
Is Kenvue stock overvalued?
Based on the P/E ratio model, Kenvue appears roughly fairly valued near its estimated fair value of $18.
What sector is Kenvue in?
Kenvue (KVUE) operates in the Consumer Staples sector, specifically in the Personal Care Products industry.

What does Kenvue do?

Kenvue is a global consumer health company selling self-care, skin health, and essential health products across three segments. Its portfolio spans iconic brands including Tylenol, Zyrtec, Nicorette, Neutrogena, Aveeno, Listerine, Johnson's, and Band-Aid, covering pain relief, cold and allergy, skincare, oral hygiene, and wound care.

Detailed Charts

Kenvue Performance

5-year trend showing revenue, gross profit, and net profit

FY2021 – FY2025

Kenvue's revenue declined 2.1% to $15.12B in FY2025, though net profit grew 42.7% to $1.47B.

Understanding Company Performance

Revenue is Kenvue's total income from operations. Gross Profit is revenue minus cost of goods sold — the higher it is relative to revenue, the stronger the company's pricing power. Net Profit is the bottom line after all expenses, taxes, and interest. Consistent growth across all three signals a healthy, expanding business. Compare with peers in the same sector.

Is Kenvue Profitable?

5-year trend showing gross, operating, and net profit margins

FY2021 – FY2025

Kenvue's net profit margin of 9.7% in FY2025 reflects thin profitability, with operating margin at 17.9% and gross margin at 58.1%.

Understanding Profitability Margins

Gross Profit Margin (GPM) shows what percentage of Kenvue's revenue remains after direct production costs. Operating Profit Margin (OPM) factors in operating expenses like R&D and SG&A. Net Profit Margin (NPM) is the final profitability after all costs including interest and taxes. Stable or improving margins indicate pricing power and cost discipline.

Kenvue Revenue & Earnings Growth

5-year trend showing revenue and diluted EPS

FY2021 – FY2025

Kenvue's revenue declined 2.1% YoY in FY2025, though EPS grew 40.7%, suggesting cost discipline despite top-line weakness.

Understanding Revenue & Earnings Growth

Revenue is Kenvue's total income from operations — the top line. Diluted EPS (Earnings Per Share) is net income divided by all shares that could exist if stock options, RSUs, and convertibles were exercised. Revenue shows how fast the business is growing; EPS shows how much of that growth reaches shareholders after all costs and dilution. Healthy companies tend to grow both in tandem; when revenue grows but EPS shrinks, margins are compressing. Use our stock screener to compare growth profiles across companies.

Kenvue Compound Annual Growth Rate (CAGR)

Metric 1-Year 5-Year 10-Year
Revenue -2.1% +0.9% N/A
Net Income +42.7% N/A N/A
EPS +40.7% N/A N/A
Share Price -8.9% N/A N/A

Kenvue's 5-year revenue CAGR of 0.9% reflects slow growth, however EPS CAGR is unavailable due to negative earnings at the start of this period.

Kenvue Quarterly Performance

Quarterly revenue and net income with a weekly share-price overlay

Upgrade to see the full 5 years (20 quarters) of quarterly data.

FY2025 – FY2026

How to Read Quarterly Performance

Quarterly revenue and net income are Kenvue's most recent three-month results. Each bar shows net income nested inside revenue, since profit is the slice of revenue left after all costs; the taller the green portion relative to the blue, the more of each sales dollar reached the bottom line. A bar below zero is a quarterly loss.

For a long-term view, compare each quarter with the same quarter a year earlier (year-over-year), not with the previous quarter — sequential change is mostly seasonality (for many businesses the holiday quarter is always the biggest). Then watch the trend across several years: is year-over-year revenue growth accelerating or fading; is net income growing at least as fast as revenue (expanding vs compressing margins)? One quarter is noise — the multi-quarter trend is the signal.

Kenvue Share Price vs Book Value

Kenvue (KVUE) share price vs book value per share — FY2020 – FY2025

Understanding Share Price vs Book Value

Share Price is what the market pays per share of Kenvue. Book Value per Share (BVPS) is the company's net equity divided by diluted shares — the accounting floor if the company were liquidated today. When price tracks close to book value the market sees the company as a steady asset; when price runs far above book the market is paying up for expected future earnings. For banks, book value is the primary valuation anchor; for most other companies it's one signal among many.

Unlock Valuation Analysis

Get fair value estimates from multiple valuation models and see whether a stock is undervalued or overvalued.

  • Multi-model fair value estimates (P/E, DCF, EPS Growth)
  • Undervalued/overvalued assessment with upside potential
  • Compare fair values across methodologies

Kenvue Free Cash Flow

5-year trend — cash generated after reinvestment

FY2021 – FY2025

Kenvue's free cash flow of $1.72B in FY2025 represents a 11.4% FCF margin — healthy cash generation supporting dividends, buybacks, or debt reduction.

Understanding Free Cash Flow

Free Cash Flow (FCF) is Kenvue's operating cash flow minus capital expenditure — the cash left over after maintaining and growing the business. Unlike net profit, FCF strips out non-cash items (depreciation, stock-based compensation) and includes actual cash spent on assets. Positive FCF means the company can pay dividends, buy back shares, reduce debt, or make acquisitions without raising capital. Consistently negative FCF signals the company is burning cash and may need external funding.

Kenvue Financial Ratios

Balance sheet strength and debt servicing capacity

FY2021 – FY2025

Debt-to-Equity

0.79

▼ from 0.88

Current Ratio

0.96

→ stable

Interest Coverage

7.1x

▲ from 4.27

Kenvue has a debt-to-equity ratio of 0.79, a current ratio of 0.96, interest coverage of 7.1x in FY2025, which indicate a well-capitalized balance sheet with comfortable debt levels.

Understanding Financial Health

Debt-to-Equity (D/E) measures how much debt the company carries relative to shareholder equity — lower means less leverage risk. Current Ratio divides current assets by current liabilities — above 1.0 means the company can cover short-term obligations. Interest Coverage is operating income divided by interest expense — higher means the company earns well above its debt payments. Together these three metrics reveal whether a company can weather downturns without financial distress.

Kenvue Shares Outstanding

Diluted share count per fiscal year — labels show year-over-year change

FY2021 – FY2025

Kenvue's diluted shares grew 0.1% YoY in FY2025 — minor dilution typical of routine stock-based compensation.

Understanding Shares Outstanding

Diluted shares outstanding counts every share of Kenvue that could exist if all stock options, RSUs, and convertibles were exercised. A shrinking count signals buybacks (returning cash to shareholders by reducing the denominator of EPS). A growing count signals dilution — usually from stock-based compensation, secondary offerings, or stock-funded acquisitions. Routine 1–2% growth is typical at large-cap tech companies that pay employees in equity; sustained growth above 5% warrants a look at the cause.

Unlock Full Analysis

Unlock 10-year interactive charts, all 5 valuation models, and full screener access.